Unión Europea - estonio - EMA (European Medicines Agency)

swedish orphan biovitrum ab (publ) - avatrombopag maleate - trombotsütopeenia - antihemorraagilised ained - doptelet on näidustatud ravi raske trombotsütopeenia täiskasvanud patsientidel, kellel on krooniline maksahaigus, kes on kavandatud läbima invasiivne protseduur. doptelet is indicated for the treatment of primary chronic immune thrombocytopenia (itp) in adult patients who are refractory to other treatments (e. kortikosteroidid, immunoglobuliinid).

Unión Europea - estonio - EMA (European Medicines Agency)

bayer ag - darolutamide - prostatic kasvajad, kastreerimine-vastupidavad - endokriinset ravi - nubeqa is indicated for the treatment of adult men with- non metastatic castration resistant prostate cancer (nmcrpc) who are at high risk of developing metastatic disease (see section 5. - metastatic hormone sensitive prostate cancer (mhspc) in combination with docetaxel and androgen deprivation therapy (see section 5.

Unión Europea - estonio - EMA (European Medicines Agency)

recordati rare diseases - osilodrostat fosfaat - cushingi sündroom - kortikosteroidid süsteemseks kasutamiseks - isturisa on näidustatud ravi sisemise cushingi sündroom täiskasvanutel.

Unión Europea - estonio - EMA (European Medicines Agency)

tetris pharma b.v - glucagon - diabeet mellitus - pankrease hormoonid, hormoonid glycogenolytic - ogluo is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.

Unión Europea - estonio - EMA (European Medicines Agency)

vetoquinol - triptorelin acetate - hüpofüüsi ja hüpotaalamuse hormoonid ja analoogid - pigs (sows for reproduction) - for the synchronisation of ovulation in weaned sows to enable a single fixed-time artificial insemination.

Unión Europea - estonio - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - dostarlimab - endometrial neoplasms - antineoplastic agents and antibody drug conjugates - jemparli is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dmmr)/microsatellite instability-high (msi h) recurrent or advanced endometrial cancer (ec) that has progressed on or following prior treatment with a platinum-containing regimen.

Estonia - estonio - Ravimiamet

laboratorios calier s.a. - folliikulit stimuleeriv hormoon+lutropiin - süstelahuse pulber ja lahusti - 500rÜ+500rÜ 1tk

Unión Europea - estonio - EMA (European Medicines Agency)

gedeon richter plc. - drospirenone, estetrol monohydrate - contraceptives, oral - suguhormoonid ja genitaalsüsteemi, - oral contraceptive.

Unión Europea - estonio - EMA (European Medicines Agency)

gilead sciences ireland uc - sacituzumab govitecan - breast neoplasms; triple negative breast neoplasms - antineoplastilised ained - trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mtnbc) who have received two or more prior systemic therapies, including at least one of them for advanced disease.

Estonia - estonio - Ravimiamet

interfish halszaporito es tanacsado kft. - gonadotropiini vabastava hormooni analoog+metoklopramiid - süste-/infusioonilahuse pulber - 25mcg+20mg 1tk 100tk 1tk